JP2023518376A5 - - Google Patents
Info
- Publication number
- JP2023518376A5 JP2023518376A5 JP2022555836A JP2022555836A JP2023518376A5 JP 2023518376 A5 JP2023518376 A5 JP 2023518376A5 JP 2022555836 A JP2022555836 A JP 2022555836A JP 2022555836 A JP2022555836 A JP 2022555836A JP 2023518376 A5 JP2023518376 A5 JP 2023518376A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- peptide
- use according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900807A AU2020900807A0 (en) | 2020-03-16 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020900807 | 2020-03-16 | ||
| AU2020900818 | 2020-03-17 | ||
| AU2020900818A AU2020900818A0 (en) | 2020-03-17 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020904226 | 2020-11-16 | ||
| AU2020904226A AU2020904226A0 (en) | 2020-11-16 | Compositions for treating respiratory tract infection and uses thereof | |
| PCT/AU2021/050229 WO2021184062A1 (en) | 2020-03-16 | 2021-03-16 | Compositions for treating respiratory tract infection and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518376A JP2023518376A (ja) | 2023-05-01 |
| JP2023518376A5 true JP2023518376A5 (cg-RX-API-DMAC7.html) | 2024-03-27 |
Family
ID=77767913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555836A Withdrawn JP2023518376A (ja) | 2020-03-16 | 2021-03-16 | 気道感染症を治療するための組成物およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230256059A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4121084A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023518376A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115297882A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021237981A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3171917A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021184062A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3996737A4 (en) * | 2019-07-09 | 2023-06-14 | Lateral Ip Pty Ltd | PEPTIDES AND THEIR USES |
| EP4346867A1 (en) * | 2021-05-07 | 2024-04-10 | Lateral Pharma Pty Ltd | Compositions for treating inflammatory airway disease and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20080333A0 (fi) * | 2008-05-02 | 2008-05-02 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
| CA2857686C (en) * | 2011-12-09 | 2023-01-17 | Metabolic Pharmaceuticals Pty Ltd | Use of growth hormone fragments |
| US9139626B2 (en) * | 2012-09-13 | 2015-09-22 | The Mitre Corporation | Mitrecin A polypeptide with antimicrobial activity |
| CN112218650A (zh) * | 2018-01-15 | 2021-01-12 | 单侧Ip私人有限公司 | 肽及其用途 |
| JP7751583B2 (ja) * | 2019-12-27 | 2025-10-08 | ラテラル、アイピー、プロプライエタリー、リミテッド | 環状ペプチド受容体ランチオニンシンテターゼｃ様タンパク質（ｌａｎｃｌ）及びその使用 |
-
2021
- 2021-03-16 CA CA3171917A patent/CA3171917A1/en active Pending
- 2021-03-16 WO PCT/AU2021/050229 patent/WO2021184062A1/en not_active Ceased
- 2021-03-16 CN CN202180021765.1A patent/CN115297882A/zh active Pending
- 2021-03-16 JP JP2022555836A patent/JP2023518376A/ja not_active Withdrawn
- 2021-03-16 US US17/911,972 patent/US20230256059A1/en active Pending
- 2021-03-16 AU AU2021237981A patent/AU2021237981A1/en not_active Abandoned
- 2021-03-16 EP EP21770411.3A patent/EP4121084A4/en not_active Withdrawn